Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 5, Number 2—April 1999
Dispatch

Lack of Association between First Myocardial Infarction and Past Use of Erythromycin, Tetracycline, or Doxycycline

Lisa A. JacksonComments to Author , Nicholas L. Smith, Susan R. Heckbert, J. Thomas Grayston, David S. Siscovick, and Bruce M. Psaty
Author affiliations: University of Washington, Seattle, Washington, USA

Main Article

Table 2

Cumulative duration of prescribed treatment with erythromycin, tetracycline, doxycycline, and the three agents combined, and the risk for incident myocardial infarction

Drug Cumulative
duration
(day)a Case-patients 
(n=1796) (%) Controls
(n=4882) (%) ORb
(95% CI) ORc
(95% CI)
Erythromycin 0 1,266 (70) 3,493 (72) 1.0 reference 1.0 reference
1-14 401 (22) 1,124 (23) 0.99 (0.87-1.13) 0.91 (0.79-1.05)
15-28 92 (5) 182 (4) 1.41 (1.08-1.82) 1.18 (0.89-1.54)
29+ 37 (2) 83 (2) 1.23 (0.83-1.83) 1.05 (0.69-1.59)
Tetracycline 0 1,507 (84) 4,149 (85) 1.0 reference 1.0 reference
1-14 223 (12) 564 (12) 1.11 (0.94-1.31) 1.02 (0.86-1.22)
15-28 39 (2) 88 (2) 1.24 (0.84-1.81) 1.04 (0.69-1.55)
29+ 27 (2) 81 (2) 0.95 (0.61-1.47) 0.98 (0.62-1.54)
Doxycycline 0 1,597 (89) 4,365 (89) 1.0 reference 1.0 reference
1-14 37 (2) 86 (2) 1.18 (0.79-1.74) 1.06 (0.71-1.59)
15-28 85 (5) 244 (5) 0.94 (0.73-1.22) 0.90 (0.69-1.18)
29+ 77 (4) 187 (4) 1.10 (0.84-1.45) 1.17 (0.88-1.56)
Erythromycin 0 1,021 (57) 2,821 (58) 1.0 reference 1.0 reference
tetracycline 1-14 422 (24) 1,178 (24) 0.99 (0.87-1.14) 0.93 (0.81-1.07)
or doxycycline 15-28 185 (10) 454 (9) 1.13 (0.94-1.35) 0.99 (0.81-1.20)
29+ 168 (9) 421 (9) 1.11 (0.91-1.34) 1.03 (0.84-1.26)

Main Article

Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external